B. Hervier

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

Julien Haroche, Frédéric Charlotte, Laurent Arnaud et al. · Blood · 2012 · 682 citations

Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

Julien Haroche, Fleur Cohen‐Aubart, Jean‐François Emile et al. · Blood · 2012 · 529 citations

224th ENMC International Workshop:

Yves Allenbach, Andrew L. Mammen, Olivier Benvéniste et al. · Neuromuscular Disorders · 2017 · 526 citations · Full text

Enmc International Workshop, Global Challenge, Performance Studies +1

CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients

Laurent Arnaud, B. Hervier, A. Néel et al. · Blood · 2011 · 380 citations · Full text

Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer

Mehdi Touat, Thierry Maisonobe, Omar Ben Hadj Salem et al. · Neurology · 2018 · 324 citations